NICOLE LARRISON: Open Payments
NPI 1326338369 · WARRENTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 22 payments from 12 companies in 2025. Trend: 2023 $316 · 2024 $393 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $168 |
| Novo Nordisk Inc | 3 | $58 |
| Exact Sciences Corporation | 2 | $42 |
| PFIZER INC. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $35 |
| Amgen Inc. | 2 | $27 |
| ABBVIE INC. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: BREZTRI, AIRSUPRA, Wegovy, Auvelity, UBRELVY, REXULTI, Cologuard Collection Kit, PREVNAR 20.
Industry payments across MO — which companies pay providers there.
